The European Patent Office has granted patent EP3589299B1, titled "Methods for functional maturation of iPSC and ESC derived cardiomyocytes." This patent, effective March 18, 2026, covers specific methods and systems related to the maturation of stem cell-derived heart cells.

This grant represents new intellectual property protection in the field of regenerative medicine and biotechnology. Companies involved in stem cell research, cardiac cell therapy, or drug discovery targeting cardiovascular diseases should be aware of this patent's existence and scope, as it may impact their research and development activities or potential commercialization efforts.